ORG Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

ORG Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$29K	Hold	1,000	–	–	0.01%	706
2025 Q3	$27.8K	Sell	1,000 -2	-0.2%	-$51	0.01%	707
2025 Q2	$24.2K	Buy	1,002 +2	+0.2%	+$44	0.01%	713
2025 Q1	$20.2K	Sell	1,000 -2	-0.2%	-$50	0.01%	683
2024 Q4	$23.6K	Hold	1,002	–	–	﹤0.01%	702
2024 Q3	$25.7K	Hold	1,002	–	–	﹤0.01%	628
2024 Q2	$23.3K	Buy	+1,002	New	+$25.3K	﹤0.01%	1030
2024 Q1	–	Sell	-2	Closed	-$65	–	574
2023 Q4	$65	Buy	+2	New	+$54	﹤0.01%	1096
2023 Q3	–	Sell	-1,000	Closed	-$34K	–	1375
2023 Q2	$34K	Buy	+1,000	New	+$31.4K	0.01%	756

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

ORG Partners's ARKG Position: Q4 2025 in Review

ORG Partners held its ARK Genomic Revolution ETF (ARKG) position steady in Q4 2025 at 1,000 shares worth $29K. The position accounts for 0.01% of the portfolio, ranked #706.

ORG Partners first reported a position in ARKG in Q2 2023 and has held it in 9 quarters since. The position peaked at $34K in Q2 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

ORG Partners held 1,000 shares of ARK Genomic Revolution ETF worth $29K as of Q4 2025.
ORG Partners left its ARK Genomic Revolution ETF share count unchanged in Q4 2025.
ARK Genomic Revolution ETF made up 0.01% of ORG Partners's portfolio in Q4 2025, its #706 holding.
ORG Partners first reported a position in ARK Genomic Revolution ETF in Q2 2023 and has held it in 9 quarters since.
ORG Partners's ARK Genomic Revolution ETF position peaked at $34K in Q2 2023.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.